Advertisement

Immune-Mediated Diseases: Where Do We Stand?

  • Michael R. Shurin
  • Yuri S. Smolkin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 601)

Abstract

The progress in basic immunology during the past 50–60 years has been associated with the emergence of clinical immunology as a new discipline in the 1970s. It was defined as the application of basic immunology principles to the diagnosis and treatment of patients with diseases in which immune-mediated mechanisms play an etiological role. Immune-mediated diseases such as autoimmune diseases, allergic diseases, and asthma are important health challenges in the United States and worldwide. For instance, autoimmune diseases afflict 5–8% of the US population; asthma and allergic diseases combined represent the sixth leading cause of chronic illness and disability in the United States and the leading cause among children. As shocking as these numbers and other data in this chapter are, they cannot adequately reflect the physical and emotional devastation to individuals, families, and communities coping with hundreds of immune-mediated disorders nor do they capture the enormous deleterious impact of these diseases on the economies of countries, nations, and indeed entire planet.

Keywords

Rheumatoid Arthritis Multiple Sclerosis Systemic Lupus Erythematosus Inflammatory Bowel Disease Autoimmune Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bloom, B., Dey, A.N. and Freeman, G. (2006) Summary health statistics for U.S. children: National Health Interview Survey, 2005. Vital Health Stat. 10, 1–84.Google Scholar
  2. Caffarelli, C., Cavagni, G., Pierdomenico, R., Chiari, G., Spattini, A. and Vanelli, M. (2004) Coexistence of IgE-mediated allergy and type 1 diabetes in childhood. Int. Arch. Allergy Immunol. 134, 288–294.CrossRefPubMedGoogle Scholar
  3. Carrozzi, L. and Viegi, G. (2005) Allergy and cancer: a biological and epidemiological rebus. Allergy 60, 1095–1097.CrossRefPubMedGoogle Scholar
  4. Chandra, R.K. (2002) Food hypersensitivity and allergic diseases. Eur. J. Clin. Nutr. 56 (Suppl. 3), S54–S56.CrossRefPubMedGoogle Scholar
  5. Cooper, G.S. and Stroehla, B.C. (2003) The epidemiology of autoimmune diseases. Autoimmun. Rev. 2, 119–125.CrossRefPubMedGoogle Scholar
  6. De Martinis, M., Di Benedetto, M.C., Mengoli, L.P. and Ginaldi, L. (2006) Senile osteoporosis: is it an immune-mediated disease? Inflamm. Res. 55, 399–404.CrossRefPubMedGoogle Scholar
  7. Dunavan, C.P. (2005) Tackling malaria. Sci. Am. 293, 76–83.CrossRefPubMedGoogle Scholar
  8. Elenkov, I.J., Iezzoni, D.G., Daly, A., Harris, A.G. and Chrousos, G.P. (2005) Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12, 255–269.CrossRefPubMedGoogle Scholar
  9. Enriquez, R., Hartert, T. and Persky, V. (2007) Trends in asthma prevalence and recommended number of childhood immunizations are not parallel. Pediatrics 119, 222–223.CrossRefPubMedGoogle Scholar
  10. Fleisher, T.A. (2006) Back to basics: primary immune deficiencies: windows into the immune system. Pediatr. Rev. 27, 363–372.CrossRefPubMedGoogle Scholar
  11. Frieri, M. (2003) Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann. Allergy Asthma Immunol. 90, 34–40.CrossRefPubMedGoogle Scholar
  12. Grateau, G. (2006) Autoinflammatory diseases. Acta Clin. Belg. 61, 264–269.PubMedGoogle Scholar
  13. Hartert, T.V. and Peebles, R.S., Jr. (2000) Epidemiology of asthma: the year in review. Curr. Opin. Pulm. Med. 6, 4–9.CrossRefPubMedGoogle Scholar
  14. Hirtz, D., Thurman, D.J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A.R. and Zalutsky, R. (2007) How common are the “common” neurologic disorders? Neurology 68, 326–337.CrossRefPubMedGoogle Scholar
  15. Jacobson, D.L., Gange, S.J., Rose, N.R. and Graham, N.M. (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84, 223–243.CrossRefPubMedGoogle Scholar
  16. Johnson, M.D. and Decker, C.F. (2006) Tuberculosis and HIV infection. Dis. Mon. 52, 420–427.CrossRefPubMedGoogle Scholar
  17. Kero, J., Gissler, M., Hemminki, E. and Isolauri, E. (2001) Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J. Allergy Clin. Immunol. 108, 781–783.CrossRefPubMedGoogle Scholar
  18. Kong, J.S., Teuber, S.S. and Gershwin, M.E. (2006) Potential adverse events with biologic response modifiers. Autoimmun. Rev. 5, 471–485.CrossRefPubMedGoogle Scholar
  19. Lawrence, R.C., Helmick, C.G., Arnett, F.C., Deyo, R.A., Felson, D.T., Giannini, E.H., Heyse, S.P., Hirsch, R., Hochberg, M.C., Hunder, G.G., Liang, M.H., Pillemer, S.R., Steen, V.D. and Wolfe, F. (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41, 778–799.CrossRefPubMedGoogle Scholar
  20. Melbye, M., Smedby, K.E., Lehtinen, T., Rostgaard, K., Glimelius, B., Munksgaard, L., Schollkopf, C., Sundstrom, C., Chang, E.T., Koskela, P., Adami, H.O. and Hjalgrim, H. (2007) Atopy and risk of non-Hodgkin lymphoma. J. Natl. Cancer. Inst. 99, 158–166.CrossRefPubMedGoogle Scholar
  21. Mills, P.K., Beeson, W.L., Fraser, G.E. and Phillips, R.L. (1992) Allergy and cancer: organ site-specific results from the Adventist Health Study. Am. J. Epidemiol. 136, 287–295.PubMedGoogle Scholar
  22. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846–852.CrossRefPubMedGoogle Scholar
  23. Ochs, H.D. and Notarangelo, L.D. (2004) X-linked immunodeficiencies. Curr. Allergy Asthma Rep. 4, 339–348.CrossRefPubMedGoogle Scholar
  24. Sacks, J.J., Helmick, C.G. and Langmaid, G. (2004) Deaths from arthritis and other rheumatic conditions, United States, 1979–1998. J. Rheumatol. 31, 1823–1828.PubMedGoogle Scholar
  25. Schwartzbaum, J., Ahlbom, A., Malmer, B., Lonn, S., Brookes, A.J., Doss, H., Debinski, W., Henriksson, R. and Feychting, M. (2005) Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 65, 6459–6465.CrossRefPubMedGoogle Scholar
  26. Shearer, W.T., Cunningham-Rundles, C. and Ochs, H.D. (2004) Primary immunodeficiency: looking backwards, looking forwards. J. Allergy Clin. Immunol. 113, 607–609.CrossRefPubMedGoogle Scholar
  27. Sheikh, A., Smeeth, L. and Hubbard, R. (2003) There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J. Allergy Clin. Immunol. 111, 131–135.CrossRefPubMedGoogle Scholar
  28. Shoenfeld, Y. and Zandman-Goddard, G. (2003). The History of Autoimmune Disease. In Autoimmune Diseases “The Enemy from Within”, Bio-Rad Pub., Hercules, CA, USA: 65.Google Scholar
  29. Simpson, C.R., Anderson, W.J., Helms, P.J., Taylor, M.W., Watson, L., Prescott, G.J., Godden, D.J. and Barker, R.N. (2002) Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin. Exp. Allergy 32, 37–42.Google Scholar
  30. Singh, V.K., Mehrotra, S. and Agarwal, S.S. (1999) The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol. Res. 20, 147–161.CrossRefPubMedGoogle Scholar
  31. Soderberg, K.C., Hagmar, L., Schwartzbaum, J. and Feychting, M. (2004) Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 4, 51.CrossRefPubMedGoogle Scholar
  32. Stene, L.C. and Joner, G. (2004) Atopic disorders and risk of childhood-onset type 1 diabetes in individuals. Clin. Exp. Allergy 34, 201–206.CrossRefPubMedGoogle Scholar
  33. Talbot-Smith, A., Fritschi, L., Divitini, M.L., Mallon, D.F. and Knuiman, M.W. (2003) Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am. J. Epidemiol. 157, 606–612.CrossRefPubMedGoogle Scholar
  34. Tolak, K., Omernik, A., Zdan, O., Ragus, D., Domagala-Kulawik, J., Rudzinski, P. and Chazan, R. (2006) The frequency of allergy in lung cancer patients. Pneumonol. Alergol. Pol. 74, 144–148.PubMedGoogle Scholar
  35. Toubi, E. and Shoenfeld, Y. (2007) Protective autoimmunity in cancer (Review). Oncol. Rep. 17, 245–251.PubMedGoogle Scholar
  36. Tracey, K.J. (2005). Fatal Sequence: The Killer Within. Washington, DC, Dana Press.Google Scholar
  37. Umetsu, D.T. and DeKruyff, R.H. (2006) The regulation of allergy and asthma. Immunol. Rev. 212, 238–255.CrossRefPubMedGoogle Scholar
  38. Walsh, M.C., Kim, N., Kadono, Y., Rho, J., Lee, S.Y., Lorenzo, J. and Choi, Y. (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24, 33–63.CrossRefPubMedGoogle Scholar
  39. Wang, H. and Diepgen, T.L. (2005) Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 60, 1098–1111.Google Scholar
  40. Zielonka, T.M. (2006) Tuberculosis in Poland, Europe, and world. Part I–prevalence. Pol. Merkur. Lekarski. 21, 243–252.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Departments of Pathology and ImmunologyUniversity of Pittsburgh Medical CenterPittsburghUSA
  2. 2.Research and Clinical Center for Allergy and Clinical ImmunologyMoscowRussia

Personalised recommendations